of that in the hepatic artery was sampled from a catheter in the femoral artery. The placement of all the catheters and flow probes in relation to the liver and the pancreatic venous drainage is illustrated in Fig. 1 . At the end of each study, the catheter placements were checked and in no instance had displacement occurred.
In two preliminary experiments, transit time of insulin through the liver was estimated by collecting hepatic vein samples every 10 s following the rapid injection of a measured quantity of 12V-labeled insulin.
As a result of these experiments, detailed below, hepatic ve in samples were drawn 30 s after the simultaneous collection of all the other samples.
Nineteen dogs were studied according to the following protocol:
after an equilibration period of 60 min following completion of the surgery, samples and flow measurements were taken 30, 20, 10, 5, and 1 min before insulin was infused into the portal vein at a rate of approximately 20 mU/min. Samples and measurements were then obtained after 2, 5, IO, 20, 30, 40, and 50 were derived from these data as described previously (7), with the exception that in this study the co- at a concentration of 0.1 U/ml in physiological saline containing 1 mg/ml bovine serum albumin (Nutritional Biochemicals Corporation), was infused by a Harvard infusion pump at rates 0.2 and 0.5 ml/ min. A portion of the insulin infusate from each study was retained and its insulin content was measured in the same assay as the experimental samples. Plasma insulin was measured by radioimmunoassay with dextrancoated charcoal, and plasma glucose, by the glucose oxidase method (Glucostat, Worthington Biochemical Corporation).
Pooled data are expressed as means & standard errors of the mean unless otherwise indicated.
RESULTS
He/x& insulin transit time.
Following the injection of a bolus of 12%labeled insulin into the portal vein, peak hepatic vein radioactivity was found at 20 and 30 s, respec-HARDING, BLOOM, AND FIELD tively, in the two experiments performed.
In each case the peak sample contained more than double the radioactivity of any other sample, suggesting a rapid and relatively homogenous passage of insulin through the liver. A second smaller peak was observed at 70 s, possibly representing the first recirculation of the injected, labeled insulin. Since the hepatic blood flow was measured and the volume of blood sampled from the LCHV was known, an estimate could be made of the amount of injected radioactivity recovered in the hepatic vein during the fn-st 60 s. This was 51 and 23 %, respectively, in the two studies.
Assessment of portal vein sampling error. FPsm, representing pancreatic insulin secretion, averaged 5.1 & 0.8 mU/min (0.24 mu/kg per min) during the control period in the whole group of 19 dogs. This is very similar to previous estimates of basal pancreatic insulin secretion in anesthetized dogs ((1 l-13) and unpublished observations). During the period lo-30 min after the cessation of insulin infusion, while arterial plasma glucose was still depressed, pancreatic insulin secretion was 3.4 & 0,9 mU/min.
As this change of 1.7 mU/min in pancreatic insulin secretion was small in relation to the amounts infused, the basal insulin secretion value in each experiment was deducted from the values of F,-, obtained during insulin infusion, so that the corrected values would reflect only the infused insulin. These corrected values were then integrated with respect to time to yield the term C Fp--In in milliunits which is a recovery figure for the total amount of insulin infused. Table 1 compares the value of z F,-, with the measured amount of insulin infused in each of the 19 dogs. The mean c IF,-, was 3,317 mU and the mean insulin infused was 3,297 mu. The mean recovery in the 19 dogs was 110 %. However, the standard deviation of the differences between the observed and expected figures in all the individual dogs was &2,447 mU and the percent recovery ranged from 9 to 303 %, indicating a large random error in measuring the portal vein insulin concentration.
Assessment of he@& vein sampling error. In three dogs in which the vena cava was ligated below the liver, insulin concentrations in the left common hepatic vein (LCHV) were compared with those found via catheters placed opposite the entry of the hepatic veins (Fig. 1, LOW IVC) and above this point (Fig. 1, HIGH IVC). The results of these observations during steady-state insulin infusion are depicted in Table 2 . The LCHV values correspond closely to the high IVC, whereas the relationship of the low IVC to both other vessels is inconstant.
In addition, the coeficients of variation for plasma insulin concentration in the LCHV and high IVC are 5.6 and 5.7 %, respectively, whereas for the low IVC it is 9.4 %.
Hepatic insulin extraction. Four dogs were excluded from this calculation. In two (dogs 32 and 38), the values obtained for hepatic insulin extraction were negative throughout the control period, giving no valid basis for comparison.
In a third (dog 43), hepatic vein insulin levels rose higher than either the measured or predicted portal vein insulin levels during infusion. The fourth dog (dog 36) showed no rise in hepatic vein insulin despite a rise in arterial levels. The values of Eh in the remaining 15 dogs are given in Table 3 , together with the plasma flows, the insulin values in the femoral artery, the portal, hepatic, and mesenteric veins, and the absolute rate of insulin uptake by the liver in milliunits per minute. The changes in arterial insulin concentration and Eh during insulin infusion are also shown in Fig. 2 "N","* . Selective distribution of insulin to the different hepatic lobes will also result in differential insulin concentrations within the hepatic venous bed, as found by Kanazawa and his colleagues (9). Therefore, hepatic vein sampling is another possible source of error in these studies. The occasional inappropriate finding of hepatic vein insulin levels lower than systemic has been reported by others (4, 9, 15) and ourselves (7), when we catheterized blindly the hepatic vein from the inferior vena cava. However, in the present study, hepatic vein samples were obtained from the left common hepatic vein, which carries approximately 40 % of hepatic venous blood (20) . Evidence that such samples adequately reflect mixed hepatic venous insulin concentration was obtained in three experiments in which the IVC was ligated immediately below the hepatic veins. Mean steady-state concentrations in the LCHV over a 70-min period were 83, 97, and 99 % of the corresponding samples taken from the vena cava at a point farthest away from the liver where most mixing is presumed to have occurred ( Table  2 ). The greater variation in vena caval insulin levels taken opposite the entry of the hepatic veins (low IVC) suggests that this catheter was more liable to sample small streams from lobes being perfused with variable insulin concentrations.
No obvious abnormality of catheter placement was found in the two dogs excluded from the study because of clearly erroneous hepatic vein results. In the remainder of the dogs, whereas there were occasional time points when the hepatic vein insulin concentration was less than arterial, there were no cases in which such an anomaly was consistent+ Therefore, calculation of Eh from the arterial, mesenteric vein, and left common hepatic vein plasma insulin concentrations, together with the known insulin infusion rate and hepatic artery and portal vein plasma flows, constitutes the most valid measurement during steady-state infusion. This does not apply to the measurements immediately following the start of the infusion, in which the increased extraction demonstrated appears to be artifactual. The control & of 0.42 & 0.02 corresponds closely to our previously reported value (7) and to those of other investigators (10, 12, 14, 19) . Although the slight rise in El, during the first infusion period (Fig. 2) is not statistically significant, some increase in tissue extraction, either in the liver or elsewhere, appears to be necessary to account for the 20 min taken for arterial insulin levels to rise to a steady level consistent with the abrupt fourfold increase in insulin ?ecretion" produced by the infusion. Blackard and Nelson (2) found a sharp peak of portal vein insulin occurred at 1 min after glucose infusion in man whereas the peripheral levels peaked at 5 min. It seems unlikely that this lag is due to transit time, which should not be grossly different from our value of 30 s determined in the dog; it would be consistent with a transient increase in tissue extraction. Also, in our previous report (7), hepatic insulin clearance increased within 5 min of the onset of glucose-induced insulin secretion. The transitory increase in the proportion of insulin leaving the blood during passage through the liver may represent equilibration of a tissue insulin compartment or compartments within the liver to the higher plasma concentrations.
This equilibration may in part be attributable to the binding of insulin to vascular endothelium, as has been postulated by Rasio and Conard (17) . Increasing the insulin infusion rate to 50.8 mU/min did not significantly increase & (Fig. 2) , and arterial insulin levels rose more abruptly.
By 2 min the mean rise was 40 pU/ml (897 b 0 a ove the previous value), whereas 2 min after the onset of the first infusion, the mean rise was only 4 $-J/ml (24 %)* A s arterial insulin concentration rose to a plateau between 20 and 50 min, & tended to fall slightly, but not significantly. However, during this time, arterial arterial insulin levels were proportionately greater in relation to the infusion rate than during the first infusion period. During the control period, the ratio of arterial insulin to insulin secretion was 2.9; during the first infusion (20-50 min), 1.9; during the second infusion, 3.1. This ratio should remain constant provided there is no change in either blood flow or tissue extraction coefficients. As blood flows were unchanged (Table 3) , the reduction of this ratio during the "equilibrium" portion of the first infusion period must be due to a persisting increase in either Eh or E,. Although the rise in & at this time achieved statistical significance, variations in J!& are more effective in modifying systemic insulin levels than are changes in E, because of the higher concentrations of insulin presented to the liver. Figure 5 plots the relationship between the total amount of insulin presented to the liver and the arterial insulin concentration, which should also remain constant if extractions do not change. Figure 5 , which used all the individual time plots for each dog during the control and 20-to 50-min periods of each infusion, demonstrates that during the equilibrium period of the first infusion, the rise in arterial insulin levels was not commensurate with the increased amounts of insulin presented to the liver. The time course of this divergence from linearity is similar to that observed when intraduodenal glucose was administered to dogs (7). F' ivc minutes after glucose was given, the ratio of arterial plasma insulin to total insulin delivered to the liver decreased and remained below the control ratio for 60 min. After this time, the ratio was the same as during the control period. 175 I,cU/ml, and the associated return of both & and E, to control levels under these conditions indicate that extraction of insulin by the liver and other tissues is not a saturable process at least up to these levels, which are as high as those found physiologically.
In the isolated perfused rat liver, hepatic insulin extraction exhibited saturation kinetics only at perfusate levels in excess of 2,500 pU/ml (18), well-above the highest portal vein levels achieved in either this study or in response to glucose in dogs (7). Waddell and Sussman (24) found no evidence of saturation of hepatic extraction at portal vein insulin levels of 500 pU/ml, and Turner et al. (23) and Silvers et al. (21) also concluded that the liver had a large capacity to remove insulin.
In addition to hepatic extraction of insulin, the remainder of insulin clearance occurs in the systemic and mesenteric circuits (Fig. 3) . The present data also permit calculation of plasma clearance in these compartments.
In the first and second infusion periods, respectively, mesenteric clearances were 45.0 and 63.6 ml/min, whereas systemic clearances were 146.5 and 55.3 ml/ min. This large contribution of the prehepatic splanchnic circulation to insulin disposal has not previously been recognized.
As stated earlier, mesenteric clearance during the control period cannot be quantitated because of the possible contamination of mesenteric vein blood with pancreatic venous blood. The sites and distribution of the systemic clearance are not discernible from the present data. In the present study, however, HGO started to increase toward control values 30 min after the start of insulin infusion when the arterial plasma glucose had fallen to only 90 & 4 mg/ 100 ml from a mean control value of 106 & 3 mg/ 100 ml (Fig.  4) . Despite this, arterial plasma glucose continued to fall to a nadir of 60 & 4 mg/lOO ml at the end of the infusion when HGO was back to control values. This suggests that increased peripheral glucose utilization is the major factor in maintaining insulin-induced hypoglycemia. In this connection, the persistent increase in E, found during insulin infusion may have physiological significance. When the insulin infusion was stopped a prompt rise in HGO occurred, suggesting that insulin still exerted an inhibitory effect on this function even though the value had returned to control level during the infusion. 
